Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
The active ingredient in Zepbound is tirzepatide, a GIP and GLP-1 receptor agonist
Only Wegovy now has the supporting evidence on relevant outcomes, which Novo Nordisk is set to convert into an expanded label and use with payers to broaden coverage
The analysis, conducted by researchers from the University of Oxford and supported by the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre and the Medical Research Council, revealed that taking the drug, a popular medication for type II diabetes, had no increased risk of adverse neurological or psychiatric outcomes compared to other antidiabetic medications, challenging recent concerns about the drug's safety
Call 615-708-0390 | Office & Telemedicine Appointments in our Nashville Clinic
Note that Wegovy pens should not be primed
These medications offer a modern approach to diet-free weight loss , allowing individuals to avoid the mental and emotional toll of restrictive meal plans
US$ 28.88
US$ 27.18
US$ 23.74
